维普中文期刊产品整合服务
217篇 您的检索式:作者名="Bellmunt"
    题名 作者 年代 出处 被引量
1Sorafenib tolera- bility in elderly patients with advanced renal cell carcino-ma :results from a large pooled analysis 显示文摘Procopio G Bellmunt J Dutcher J 2013Br J Cancer2013,108,2:1
2Topologies of multiterminal HVDC-VSC transmission for large offshore wind farms显示文摘Bellmunt O G Liang J Ekanayake J 2011Electric Power System Research2011,81,:1
3Randomized phaseⅢ trial of temsirolimus and bevacizumab versus interferon alfa and bev- acizumab in metastatic renal cell carcinoma 显示文摘Rini BI Bellmunt J Clancy J 2014J Clin Oncol2014,32,8:1
4Bladder cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up 显示文摘Bellmunt J Orsola A Wiegel T 2011Ann Oncal2011,22,6:1
5Randomized phase m study comparing paclitaxel / cisplatin/gemcitabine ( PCG ) and gemcitabine/cisplatin (GC) in patients with locally advanced or metastatic urothelial cancer without prior systemic therapy; EORTC intergroup study 30987 显示文摘Bellmunt J yon der Maase H Mead G 2012J Clin Oncol2012,30,10:1
6Pretreatment prognostic factors for survival in patients with advanced urothelial tumors treated in a phase I/II trial with paclitaxel, cisplatin, and gemcitabine显示文摘BELLMUNT J ALBANELL J PAZARES L 2002Cancer2002,95,:1
7Phase ID trial of bev-acizumab plus interferon alfa-2a in patients with metastatic renalcell carcinoma ( AVOREN ) : Final analysis of overall survival显示文摘Escudier B Bellmunt J Negrier S 2010J Clin Oncol2010,28,13:1
8EAU guidelines on prostate cancer, part 1 : screening, diagnosis, and local treat- ment with curative intent -update 2013 显示文摘Heidenreich A Bastian PJ Bellmunt J 2014Eur Urol2014,65,1:1
9A systematic review of neoadjuvant and adjuvant chemotherapy for muscle-invasive bladder cancer显示文摘Meeks JJ Bellmunt J Bochner BH 2012Eur Urol2012,62,3:1
10Present strategies in the treatment of metastatic renal cell carcinoma:an update on molecular targeting agents 显示文摘Bellmunt J Montagut C Albiol S 2007BJU Int2007,99,2:1
11Phase m trial of vinflunine plus best supportive care compared with best supportive alone after a platinum-containing regimen in patients with advanced transitional cell carcinoma of the urothelial tract 显示文摘Bellmunt J Th6odore C Demkov T 2009J Clin Oncol2009,27,27:1
12Prognostic factors in patients with advanced transitional cell carcinoma of the urothelial tract experiencing treatment failure with platinum-containing regimens 显示文摘Bellmunt J Choueiri TK Fougeray R 2010J Clin Oncol2010,28,11:1
13Cisplatin and gemcitabine administered every two weeks in patients with locally advanced or metastatic urothelial carcinoma and impaired renal function显示文摘Rafael Morales-Barrera Joaquim Bellmunt Cristina Suárez Claudia Valverde Marta Guix Cesar Serrano Manuel Gallén Joan Carles 2012European Journal of Cancer2012,,12:1
14Advanced glycation end product precursors impair epidermal growth factor receptor signaling 显示文摘Portero - Otin M Pamplona R Bellmunt MJ 2002Diabetes2002,51,:1
15Cisplatin and gemcitabine administered every two weeks in patients with locally advanced or metastatic urothelial carcinoma and impaired renal function显示文摘Rafael Morales-Barrera Joaquim Bellmunt Cristina Suárez Claudia Valverde Marta Guix Cesar Serrano Manuel Gallén Joan Carles 2012European Journal of Cancer2012,,12:1
16Bladder cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and fol- low-up显示文摘Bellmunt J Orsola A Wiegel T 2011Ann Onco12011,22,6:1
17Mechanisms of glycation in atherogenesis显示文摘Pamplona R Bellmunt MJ Portero M 2005Med Hypotheses2005,40,3:1
18Phase Ⅲ trial of bevacizumab plus interferon alfa-2a in patients with metastatic renal cell carcinoma (AVOREN):final analysis of overall survival显示文摘ESCUDIER B BELLMUNT J NEGRIER S 2010J Clin Oncol2010,28,13:1
19Phase III trial of bevacizumab plus interferon alfa-2a in patients with metastatic renal cell carcinoma (AVOREN): final analysis of overall survival 显示文摘Escudier B Bellmunt J Negrier S 2010J Clin Oncol2010,28,13:1
20Endobronehial metasta- ses in eoloreetal adenocareinoma显示文摘Rovirosa-Casino A Bellmunt J Salud A 1992Tumori1992,78,4:1
返回顶部 每页显示:
共11页 首页 上一页 第1页 下一页 末页 /11 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费